Islet transplantation: Need for a time-out?

Nature Clinical Practice Nephrology

Volumn 4, Issue 12, 2008, Pages 660-661

  Cravedi, Paolo ^a   Mannon, Roslyn B ^b   Ruggenenti, Piero ^a   Remuzzi, Andrea ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; GLUCOSE; INSULIN; MONOCLONAL ANTIBODY CD3; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS;

CYTOKINE RELEASE SYNDROME; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; NEOPLASM; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; SHORT SURVEY; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS REACTIVATION;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 56749158021     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0961     Document Type: Short Survey

References (14)

1. Shapiro AM et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238
2. Shapiro AM et al. (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330
3. Leichtman AB et al. (2008) Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant 8: 946-957
4. Johnston O et al. (2008) Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 19: 1411-1418
5. Nir T et al. (2007) Recovery from diabetes in mice by beta cell regeneration. J Clin Invest 117: 2553-2561
6. Monti P et al. (2008) Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 118: 1806-1814
7. Campbell PM et al. (2007) High risk of sensitization after failed islet transplantation. Am J Transplant 7: 2311-2317
8. Olyaei AJ et al. (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7: 384-389
9. Tomlanovich SJ and Vincenti F (2007) Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol 2: 198-199
10. Senior PA et al. (2007) Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant 7: 91-98
11. Fioretto P et al. (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75
12. Remuzzi G et al. (2002) Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med 346: 1145-1151
13. Haller MJ et al. (2007) Type 1 diabetes intervention trials 2007: where are we and where are we going? Curr Opin Endocrinol Diabetes Obes 14: 283-287
14. Hu CY et al. (2007) Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117: 3857-3867